Outcomes and endpoints in trials of cancer treatment: the past, present, and future
Author:
Publisher
Elsevier BV
Subject
Oncology
Reference115 articles.
1. Reflections on medical oncology: 25 years of clinical trials—where have we come and where are we going?;Booth;J Clin Oncol,2008
2. Overall survival: a gold standard in search of a surrogate: the value of progression-free survival and time to progression as end points of drug efficacy;Zhuang;Cancer J,2009
3. Equipoise lost: ethics, costs, and the regulation of cancer clinical research;Stewart;J Clin Oncol,2010
4. Taking the long view: how to design a series of phase III trials to maximize cumulative therapeutic benefit;Deley;ClinTrials,2012
5. Fool's gold, lost treasures, and the randomized clinical trial;Stewart;BMC Cancer,2013
Cited by 150 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Telehealth and Outcomes in Patients With Cancer;The Cancer Journal;2024-01
2. Reviewing the evolutive ACQ‐to‐AIE transformation of photosensitizers for phototheranostics;Luminescence;2023-12-26
3. The correlation between the costs and clinical benefits of national price-negotiated anticancer drugs for specific cancers in China;Journal of Global Health;2023-11-09
4. Early Efficacy End Points in Neoadjuvant Rectal Cancer Trials: Surrogacy Revisited;Journal of Clinical Oncology;2023-10-27
5. Comparison of clinical outcomes among cancer patients treated in and out of clinical trials;BMC Cancer;2023-08-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2023 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3